Fc Fusion technology Video

youtu.be/dlUYLacyUk0

Source: Bringing Generations Together <donotreply@wordpress.com[подробнее]

News of hepatitis C treatment

New HCV Drug Promising, Cuts Out InterferonTreatment with an investigational hepatitis C drug allowed investigators to dispense with an old stand-by -- pegylated interferon-alpha...

HCV Testing by Birth Cohort...[подробнее]

Amsterdam Molecular Therapeutics Receives Orphan Designation in the EU for Hemophilia B Gene Therapy

www.amtbiopharma.com/news/128/182/Amsterdam-Molecular-Therapeutics-Receives-Orphan-Designation-in-the-European-Union-for-Hemophilia-B-Gene-Therapy.html

Source: Bringing Generations Together <donotreply@wordpress.com[подробнее]

HCV Drug Shows Promise in HIV

BOSTON -- The recently approved hepatitis C drug boceprevir (Victrelis) is effective in patients co-infected with HIV, according to interim results of a phase II study....[подробнее]

Transgene's vaccine for hepatitis C attracts potential partners

Transgene began talks with potential development partners for TG4040, an investigational vaccine for chronic hepatitis C, said Chief Financial Officer Stephane Boissel. The company hopes to reach a deal in 2012 or 2013. Transgene...[подробнее]

Pharmasset drug exhibits 100% response rate in hepatitis C study

Patients with genotype 2 and 3 hepatitis C were cured after 12 weeks of treatment with Pharmasset's drug candidate PSI-7977 plus standard therapy of ribavirin and interferon, according to clinical data presented at a meeting of...[подробнее]

FDA OKs relaunch of immunodeficiency drug by Octapharma

The FDA is allowing Octapharma to resume distribution of immunoglobulin product Octagam 5%. Last year, Octapharma voluntarily pulled certain batches of the therapy after thromboembolic events were reported. Octapharma and the FDA...[подробнее]